An Xcel Energy crew works on the power lines at the intersection of Baseline Road and Foothills Parkway in Boulder in September. WINDSOR, Colo – Future Legends announces The Olsgard Team powered by C3 ...
Approval is based on results from the Phase III VALIANT trial (NCT05067127), in which Empaveli demonstrated a 68% reduction in proteinuria, stabilization of kidney function, and a significant ...
C3 glomerulopathy (C3G) and immune complex membranoproliferative glomerulonephritis (IC-MPGN) are rare and progressive kidney diseases, caused by problems in the immune system. They are two distinct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results